Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.
Porter
D L
DL
Harvard Medical School, Boston, MA.
Orloff
G J
GJ
Antin
J H
JH
D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000517:prevention & control; D006566:Herpesviridae Infections; D004854:Herpesvirus 4, Human; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000628:therapy; D017708:Leukocyte Transfusion; D007963:Leukocytes, Mononuclear / Q000637:transplantation*; D016393:Lymphoma, B-Cell / Q000209:etiology / Q000628:therapy*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000209:etiology / Q000628:therapy*; D014184:Transplantation, Homologous; D014412:Tumor Virus Infections